Ultra-Low-Level Laser Stimulation of LU7 Lieque Promotes Breath Functionality: Could it be of help in Covid 19 Rehabilitation? - A Multiple Case Report

The burden of post COVID rehabilitation is and will be a strong concern for healthcare stakeholders. The Traditional Chinese Medicine is suggesting the application of acupuncture as a dependable tool to be inserted in the rehabilitation project. Libralux, an ultra-low-level-laser stimulator has proven its effectiveness as acupuncture stimulator. In this paper we report the respiratory cycle modifications obtained through the stimulation with Libralux of the acupoint LU7 LieQue of three healthy individuals. Modifications were observed instrumentally by means of an innovative high-resolution camera plotting the chest expansion vs. time. The results demonstrate a remarkable increase in respiration depth and in the contemporary reduction of the respiration frequency within 20 minutes from the 20 sec bilateral stimulation of LU7 LieQue acupoint. The worthiness of a specific full double-blind trial is suggested also in view of the marginal contra-indications, the rapid execution and, most of all, the great potential benefit of the inclusion of a laser acupunctural stimulation in the post COVID rehabilitation project.

Download Full-text

Comparative Effects of the Stimulation of BL10, BL11, and GB34 Acupuncture Points with P6 Point using a Low-Level Laser on the Prevention of Vomiting after Strabismus Surgery: A Randomized, Double-Blind, Controlled Clinical Trial

Iranian Red Crescent Medical Journal ◽

10.5812/ircmj.64713 ◽

2019 ◽

Vol In Press (In Press) ◽

Author(s):

Masoumeh Albooghobeish ◽

Ahmadreza Mohtadi ◽

Vahid Saidkhani ◽

Golamreza Khataminia ◽

Habib Fallah ◽

...

Keyword(s):

Clinical Trial ◽

Strabismus Surgery ◽

Controlled Clinical Trial ◽

Acupuncture Points ◽

Double Blind ◽

Low Level ◽

Low Level Laser ◽

Level Laser ◽

Stimulation Of

Download Full-text

Doppelblinde, randomisierte, placebokontrollierte Low-Level-Laser Therapiestudie bei Patienten mit primärem Raynaudphänomen

VASA ◽

10.1024/0301-1526.31.2.91 ◽

2002 ◽

Vol 31 (2) ◽

pp. 91-94 ◽

Cited By ~ 14

Author(s):

Hirschl ◽

Katzenschlager ◽

Ammer ◽

Melnizky ◽

Rathkolb ◽

...

Keyword(s):

Laser Therapy ◽

Raynaud’S Phenomenon ◽

Raynaud's Phenomenon ◽

Low Level Laser Therapy ◽

Double Blind ◽

Double Blind Placebo ◽

Low Level ◽

Low Level Laser ◽

Level Laser ◽

Primary Raynaud’S Phenomenon

Background: No causal treatment of primary Raynaud’s phenomenon is available due to its unclear aetiology. Low level laser therapy (LLLT) is applied in a multitude of medical conditions often without sufficient evidence of efficacy and established mechanisms. To asses the effect of this therapy in patients with primary Raynaud’s phenomenon a randomised, double blind, placebo controlled cross over study was designed. Patients and methods: Absolute and relative frequency and intensity of vasospastic attacks during three weeks of either LLLT or placebo therapy and results of infrared thermography before onset and at the end of both therapy sequences were evaluated in 15 patients with primary Raynaud’s phenomenon. Results: Frequency of Raynaud’s attacks was not significantly affected by low level laser therapy. Compared to placebo a significantly lower intensity of attacks during laser irradiation was observed, but no transfer effect occurred. Additionally the mean temperature gradient after cold exposure was reduced after laser irradiation, while the number of fingers showing prolonged rewarming was unaffected. Conclusion: Though further studies are necessary to confirm these results we could demonstrate for the first time in a double blind placebo controlled clinical trial that low laser therapy is a potential candidate for an effective therapy of Raynaud`s phenomenon, although effects seem to be of short duration.

Download Full-text